Skip to main content

Table 2 Predictors of Non-alcoholic fatty liver disease

From: Non-alcoholic fatty liver disease in Tanzania: prevalence, determinants, and diagnostic performance of triglycerides-glucose index and triglycerides-glucose index –body mass index compared to the hepatic ultrasound in overweight and obese individuals

Variable

Crude Odds Ratio

Adjusted Odds Ratio

OR (95%CI)

P value

OR (95% CI)

P value

Advanced age (> 58 years)

1.5 (0.8–2.8)

0.24

α

α

Female sex

1.2 (0.6–2.4)

0.57

α

α

Staying in urban (ref. rural)

1.7 (0.9–3.1)

0.13

α

α

Overweight

0.5 (0.2–1.3)

0.15

α

α

Obesity class I

0.6 (0.3–1.1)

0.09

2.0 (0.5–2.9)

0.75

Obesity class III

2.7 (1.1–3.4)

0.03

1.1 (0.3–4.0)

0.86

Hypertension

1.7 (0.8–3.8)

0.13

α

α

Diabetes

1.8 (1.0–3.5)

0.06

1.1 (0.5–2.4)

0.19

High systolic blood pressure (≥ 134 mmHg)

1.6 (0.9–3.1)

0.13

α

α

High diastolic blood pressure (≥ 83 mmHg)

1.7 (0.9–3.3)

0.09

1.4 (0.6–3.1)

0.39

High fasting blood glucose (≥ 104 mg/dl)

2.1 (1.1–4.1)

0.02

0.9 (0.4–2.2)

0.81

High triglycerides (≥ 121 mg/dl)

4.5 (2.2–9.0)

< 0.001

0.7 (0.2–2.5)

0.56

Low high-density lipoprotein (≤ 42 mg/dl)

2.1 (1.1–4.0)

0.03

1.8 (0.8–3.9)

0.63

High uric acid (≥ 360 μmol/L)

2.4 (1.3–4.7)

0.008

2.1 (1.1–4.7)

0.04

Triglyceride-glucose index ≥8.99

9.4 (4.5–19.3)

< 0.001

7.7 (2.0–29.6)

0.003

Triglyceride-glucose index-BMI ≥293.4

3.7 (1.8–7.3)

< 0.001

1.9 (0.8–4.7)

0.16

  1. OR odds ratio, CI confidence interval, BMI body mass index
  2. α Not included in multivariate analysis